Narpinder Malhi, MD

Department of Psychiatry and Behavioral Health, ChristianaCare, Newark, DE · 5 sessions at 1 meeting · 1 upcoming

Topics

Autism & Neurodevelopmental Disorders (4)Child & Adolescent (4)Deprescribing & Polypharmacy (2)ADHDAntipsychotic PrescribingDrug Interactions & SafetySuicide & Self-Harm

Sessions

AACAP Annual Meeting 2026

October 26–31, 2026 · Atlanta, GA · Full program

  • SessionChairBridging the Gap: Clinical Approaches to Suicide Risk Assessment and Interventions in ASD and Intellectual Developmental Disorder

    October 27, 2026, 09:00–11:00

    Clinical perspectives session on assessing suicide risk and delivering interventions for youth with autism spectrum disorder and intellectual developmental disorder.

    Autism & Neurodevelopmental DisordersChild & AdolescentSuicide & Self-Harm

  • PosterNeuroleptic Malignant Syndrome in Pediatric Patients: Patterns of Vulnerability and Prescribing Risk

    October 29, 2026, 13:00–15:00

    Explores patterns of vulnerability and prescribing-related risk for neuroleptic malignant syndrome in pediatric patients.

    Antipsychotic PrescribingChild & AdolescentDrug Interactions & Safety

  • LectureImpact of Comorbid ASD on Treatment and Clinical Outcomes of ADHD

    October 29, 2026, 14:30–16:30

    Examines how co-occurring autism spectrum disorder affects treatment response and outcomes in ADHD.

    ADHDAutism & Neurodevelopmental Disorders

  • SessionSmarter Prescribing in Youth With Intellectual Developmental Disorder: Treating Aggression, Reducing Polypharmacy, and Addressing Supplements

    October 31, 2026, 13:00–15:00

    Clinical perspectives on prescribing for youth with intellectual developmental disorder, covering aggression treatment, reducing polypharmacy and the use of supplements.

    Autism & Neurodevelopmental DisordersChild & AdolescentDeprescribing & Polypharmacy

  • LecturePsychotropic Polypharmacy in Intellectual Developmental Disorder: Key Considerations and Strategies for Safe Discontinuation

    October 31, 2026, 13:00–15:00

    Covers considerations for reducing and safely discontinuing multiple psychotropic medications in youth with intellectual developmental disorder.

    Autism & Neurodevelopmental DisordersChild & AdolescentDeprescribing & Polypharmacy

Presents with

Jennifer McLaren (2) · Aakanksha Singh · Carmen Lopez-Arvizu · Daniel A. Waschbusch · Gurkirat Kaur Bhangu · James G. Waxmonsky · Jill Hinton · Kathleen A. Koth · Kyle Jackson · Lisa C. Yeh · Lisa M. Horowitz · Margaret D. Weiss · Michael Murray · Pankhuree Vandana · Raman Baweja · Ruwaydah Sideek · Samuel Huo · Suzanne M. Rybczynski

Speaker listings come from official conference programs and may change — confirm on each meeting's site. Spot an error? Names printed differently on different programs are merged conservatively.

Is this you? Add your photo

Send us a headshot and we'll show it on this page and next to your sessions. Every submission is reviewed by a person before it goes live; we never share your email.

Browse the directory

Recurring meetings